Effect of Recombinant Human 66 Insulin-like Growth Factor I and Early Total Parenteral Nutrition on Immune Depression Following Severe Head Injury

All articles published, including editorials, letters, and book reviews, represent the opinions of the authors and do not reflect the policy of the American Medical Association, the Editorial Board, or the institu­ tion with which the author is affiliated, unless this is clearly specified. James S. Todd, MD Executive Vice President Kenneth E. Monroe Deputy Executive Vice President Larry E. Joyce Senior Vice President George D. Lundberg, MD Editor-in-Chief, Scientific Publications Robert L. Kennett Vice President, Publishing Nawin Gupta, PhD Director, Publishing Operations Division Cheryl Iverson Director, Editorial Processing Division Michael D. Springer Associate Publisher John P. Cahill Manager, Advertising Sales Geoffrey A. Flick Manager, Marketing Services

[1]  C. McCall,et al.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. , 1993, The Journal of clinical investigation.

[2]  S. Vesconi,et al.  Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. , 1992, Archives of surgery.

[3]  S. Suter,et al.  High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. , 1992, The American review of respiratory disease.

[4]  L Schweiberer,et al.  Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. , 1992, Archives of surgery.

[5]  D. Remick,et al.  Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. , 1992, Journal of immunology.

[6]  I. Chaudry,et al.  Chloroquine attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. , 1991, Blood.

[7]  H. Redl,et al.  Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. , 1991, The Journal of infectious diseases.

[8]  A. Severn,et al.  A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide. , 1991, Journal of immunological methods.

[9]  C. Dinarello.  The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. , 1991, The Journal of infectious diseases.

[10]  L. Moldawer,et al.  IL-8 in septic shock, endotoxemia, and after IL-1 administration. , 1991, Journal of immunology.

[11]  R. Danner,et al.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents , 1991, The Journal of experimental medicine.

[12]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[13]  I. Ginsburg,et al.  Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. , 1989, The American journal of pathology.

[14]  J. Parrillo,et al.  Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. , 1989, The New England journal of medicine.

[15]  T. Clemmer,et al.  Sepsis syndrome: a valid clinical entity , 1989 .

[16]  T. Mathew,et al.  Plasma concentrations of granulocytic elastase-alpha 1-proteinase inhibitor complex in patients with severe head injury, multiple trauma or cerebral bleeding. , 1989, Clinical biochemistry.

[17]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[18]  J. Larrick.  Native interleukin 1 inhibitors. , 1989, Immunology today.

[19]  S. Haskill,et al.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. , 1988, Journal of immunology.

[20]  R. Cotran,et al.  Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. J. Young,et al.  Manifestations of sepsis. , 1987, Archives of internal medicine.

[22]  J. Kenney,et al.  Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity. , 1987, Journal of immunology.

[23]  K. Radtke,et al.  Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections , 1987, European journal of haematology.

[24]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[25]  A. Waage,et al.  ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.

[26]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[27]  H. Redl,et al.  Posttraumatic Complications and Inflammatory Mediators , 1986 .

[28]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.

[29]  H. Ochs,et al.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. , 1986, Journal of immunology.

[30]  J. Gamble,et al.  Stimulation of neutrophils by tumor necrosis factor. , 1986, Journal of immunology.

[31]  C. Haslett,et al.  Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. , 1986, The Journal of clinical investigation.

[32]  R. Schleimer,et al.  Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. , 1986, Journal of immunology.

[33]  J. Gamble,et al.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Jochum,et al.  Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. , 1985, Surgery.

[35]  J. Harlan.  Leukocyte-endothelial interactions. , 1985, Blood.

[36]  S. Weiss,et al.  Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites. , 1984, The Journal of clinical investigation.

[37]  S. Weiss,et al.  Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. , 1981, The Journal of clinical investigation.

[38]  H. Jacob,et al.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. , 1978, The Journal of clinical investigation.

[39]  K. Havemann,et al.  Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. , 1977, Blood.

[40]  W. Machleidt,et al.  Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches. , 1993, Agents and actions. Supplements.

[41]  H. Sugimoto,et al.  Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure. , 1991, Annals of surgery.

[42]  F. Moore,et al.  Tumor necrosis factor and endotoxin can cause neutrophil activation through separate pathways. , 1991, Archives of surgery.

[43]  C. Robertson,et al.  Neutrophil elastase levels and major trauma in man. , 1989, Intensive Care Medicine.

[44]  M. Jochum,et al.  Pathobiochemical mechanisms in inflammation , 1989 .

[45]  D. Inthorn,et al.  Possible Use of the Monocyte/Macrophage Activation Marker Neopterin for Clinical Monitoring of Sepsis-Related Multiorgan Failure , 1989 .

[46]  H. Redl,et al.  Validity of the elastase assay in intensive care medicine. , 1989, Progress in clinical and biological research.

[47]  A. Janoff.  Elastase in tissue injury. , 1985, Annual review of medicine.